About MicrobeDx
MicrobeDx is a molecular diagnostics company that seeks to revolutionize clinical microbiology. Overprescription of antibiotics has lead to an ongoing public health crisis, all precipitated by a lack of timely information. Our molecular assays are able to identify bacteria in direct testing of a clinical specimen and determine which antibiotics the pathogen is resistant and susceptible to. Our AST assay is phenotypic, measuring the bacterial growth response to an antibiotic. Phenotypic AST assays are applicable to all bacterial pathogens and, unlike genotypic assays, they don't need to keep up with an ever-expanding set of targets and genes that encode antibiotic resistance. Our assay enable physicians to have actionable information with 3 hours of patient encounter, allowing them to intelligently select the first dose of antibiotic a patient receives. Most importantly, the doctor can rule out the vast majority of patients who don't have an infection and thus don't need an antibiotic.
|
|
|
1-10 employees
View all MicrobeDx employees
|
|
Biotechnology Research
|
|
2015
|
|
Clinical Microbiology, Antimicrobial Susceptibility Testing, Bacterial Identification, Molecular Diagnostics Innovation
|
MicrobeDx Alternatives
Frequently Asked Questions about MicrobeDx
The decision makers in MicrobeDx are Colin Halford, Warren Otto, etc. Click to Find MicrobeDx decision makers emails.
MicrobeDx Staff Directory
Search MicrobeDx Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
